Copenhagen Infrastructure Partners completes acquisition of New York onshore wind development portfolio
Globe Newswire15-04-2024, 18:30
Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition 9-11-2024, 02:51